A COST-CONSEQUENCE ANALYSIS OF PONATINIB VERSUS IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED PHILADELPHIA-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA IN THE UNITED STATES

被引：0
|
作者：
Hernandez, L. G. [1 ]
Davies, S. [2 ]
Li, C. [3 ]
Reddick, L. E. [1 ]
Jensen, I [2 ]
机构：
[1] Takeda Pharmaceut Amer Inc, Lexington, MA USA
[2] PRECISIONheor, Precis Value & Hlth, Boston, MA USA
[3] Takeda Dev Ctr Amer Inc, Lexington, MA USA
来源：
VALUE IN HEALTH | 2024年 / 27卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE165
引用
收藏
页码：S88 / S88
页数：1
相关论文
共 50 条
  • [41] Immunomodulatory Effect of Dasatinib Plus Blinatumomab Versus Ponatinib Plus Blinatumomab in Newly Diagnosed Ph plus Acute Lymphoblastic Leukemia Patients
    Ansuinelli, Michela
    De Propris, Maria Stefania
    Puzzolo, Maria Cristina
    Peragine, Nadia
    Quacquarelli, Tiziano
    Capria, Saveria
    Skert, Cristina
    Mancini, Valentina
    Sica, Simona
    Lussana, Federico
    Borlenghi, Erika
    Cerrano, Marco
    Vallisa, Daniele
    Cardinali, Valeria
    Chiaretti, Sabina
    Guarini, Anna
    Foa, Robin
    BLOOD, 2024, 144 : 838 - 839
  • [42] Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
    Ribera, Josep-Maria
    Prawitz, Thibaud
    Freitag, Andreas
    Sharma, Anuj
    Dobi, Balazs
    Rizzo, Federica
    Sabatelli, Lorenzo
    Patos, Petros
    ADVANCES IN THERAPY, 2023, 40 (07) : 3087 - 3103
  • [43] Ponatinib vs. Imatinib as Frontline Treatment for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: A Matching Adjusted Indirect Comparison
    Josep-Maria Ribera
    Thibaud Prawitz
    Andreas Freitag
    Anuj Sharma
    Balázs Dobi
    Federica Rizzo
    Lorenzo Sabatelli
    Petros Patos
    Advances in Therapy, 2023, 40 : 3087 - 3103
  • [44] Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study
    A Delannoy
    E Delabesse
    V Lhéritier
    S Castaigne
    F Rigal-Huguet
    E Raffoux
    F Garban
    O Legrand
    S Bologna
    V Dubruille
    P Turlure
    O Reman
    M Delain
    F Isnard
    D Coso
    P Raby
    A Buzyn
    S Caillères
    S Darre
    C Fohrer
    A Sonet
    C Bilhou-Nabera
    M-C Béné
    H Dombret
    P Berthaud
    X Thomas
    Leukemia, 2006, 20 : 1526 - 1532
  • [45] Imatinib plus chemotherapy in adult patients with philadelphia chromosome-positive acute lymphoblastic leukemia (PH-ALL): An exploratory cost-effectiveness analysis for the United Kingdom
    Stephens, J.
    Carpiuc, K. T.
    Botteman, M. F.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 410 - 411
  • [46] Imatinib and methylprednisolone alternated with chemotherapy improve the outcome of elderly patients with Philadelphia-positive acute lymphoblastic leukemia: results of the GRAALL AFR09 study
    Delannoy, A.
    Delabesse, E.
    Lheritier, V.
    Castaigne, S.
    Rigal-Huguet, F.
    Raffoux, E.
    Garban, F.
    Legrand, O.
    Bologna, S.
    Dubruille, V.
    Turlure, P.
    Reman, O.
    Delain, M.
    Isnard, F.
    Coso, D.
    Raby, P.
    Buzyn, A.
    Cailleres, S.
    Darre, S.
    Fohrer, C.
    Sonet, A.
    Bilhou-Nabera, C.
    Bene, M-C
    Dombret, H.
    Berthaud, P.
    Thomas, X.
    LEUKEMIA, 2006, 20 (09) : 1526 - 1532
  • [47] Combination of Olverembatinib and VP Regimen for Newly Diagnosed Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
    Tan, Xu
    Chen, Guo
    Ma, Yingying
    Wang, Maihong
    Wen, Qin
    Liu, Hong
    Zhang, Xi
    Zhang, Cheng
    BLOOD, 2024, 144 : 1449 - 1449
  • [48] Early molecular response to posttransplantation imatinib determines outcome in MRD+ Philadelphia-positive acute lymphoblastic leukemia (Ph+ ALL)
    Wassmann, B
    Pfeifer, H
    Stadler, M
    Bornhäuser, M
    Bug, G
    Scheuring, UJ
    Brück, P
    Stelljes, M
    Schwerdtfeger, R
    Basara, N
    Perz, J
    Bunjes, D
    Ledderose, G
    Mahlberg, R
    Binckebanck, A
    Gschaidmeier, H
    Hoelzer, D
    Ottmann, OG
    BLOOD, 2005, 106 (02) : 458 - 463
  • [49] Chemotherapy-Free Combination of Blinatumomab and Ponatinib in Adults with Newly Diagnosed Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Updates from a Phase II Trial
    Haddad, Fadi G.
    Jabbour, Elias
    Short, Nicholas J.
    Jain, Nitin
    Huang, Xuelin
    Montalban-Bravo, Guillermo
    Kadia, Tapan M.
    Daver, Naval
    Nasnas, Cedric
    Mayor, Ejiroghene
    Nasnas, Patrice Eric
    Deen, Wuliamatu
    Zoghbi, Marianne
    Thankachan, Jennifer
    Loiselle, Christopher
    Garris, Rebecca
    Ravandi, Farhad
    Kantarjian, Hagop M.
    BLOOD, 2023, 142
  • [50] Next-generation sequencing-based analysis to assess the pattern of relapse in patients with Philadelphia-positive acute lymphoblastic leukemia
    Ahn, Jae-Sook
    Kim, Taehyung
    Jung, Sung-Hoon
    Ahn, Seo-Yeon
    Song, Ga-Young
    Kim, Mihee
    Yang, Deok-Hwan
    Lee, Je-Jung
    Kim, Mi Yeon
    Moon, Joon Ho
    Zhang, Zhaolei
    Kim, Hyeoung-Joon
    Kim, Dennis Dong Hwan
    EJHAEM, 2022, 3 (04): : 1145 - 1153
12345